Search - tctmd.com

Displaying 161 - 180 of 257

Sort: Relevancy | Date

News Daily News

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

Todd Neale

September 24, 2015

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

Todd Neale

September 24, 2015

News Daily News

Un Estudio de Registro Vincula las PCI por OTC a una Mejor Supervivencia vs. Tratamiento Médico y CABG

September 17, 2015

News Daily News

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

September 17, 2015

News Industry News

Sorin Group Obtains Health Canada Approval for Perceval, Its Next Generation Sutureless Valve

August 05, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Daily News

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

August 04, 2015

Presentation CICT 2015

Who Should Undergo Unprotected Left Main Coronary Artery Stenting: The European Perspective

Presenter: Antonio Colombo

July 31, 2015

News Industry News

QT Vascular Announces The Allowance Of Four New Patents

July 15, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Industry News

CorPath® System Robotically Deployed Bioresorbable Vascular Scaffold During Live Broadcast of a Complex Coronary Intervention at 2015 C3 Conference

June 18, 2015

News Industry News

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

June 17, 2015

News Conference News ACC 2015

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

L.A. McKeown

March 16, 2015

News Daily News

For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI

Yael L. Maxwell

January 28, 2015

News Daily News

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

Todd Neale

December 22, 2014

News Daily News

La Revascularización Híbrida para la Enfermedad Multivaso parece Viable y Segura

December 04, 2014

News Daily News

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

December 04, 2014

News Daily News

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

L.A. McKeown

November 06, 2014

News Daily News

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

L.A. McKeown

November 06, 2014

News Daily News

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

L.A. McKeown

November 06, 2014

Advertisement

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

Study Supports Multiarterial CABG for Multivessel CAD

Un Estudio de Registro Vincula las PCI por OTC a una Mejor Supervivencia vs. Tratamiento Médico y CABG

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

Sorin Group Obtains Health Canada Approval for Perceval, Its Next Generation Sutureless Valve

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

Who Should Undergo Unprotected Left Main Coronary Artery Stenting: The European Perspective

QT Vascular Announces The Allowance Of Four New Patents

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

CorPath® System Robotically Deployed Bioresorbable Vascular Scaffold During Live Broadcast of a Complex Coronary Intervention at 2015 C3 Conference

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

La Revascularización Híbrida para la Enfermedad Multivaso parece Viable y Segura

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content